1. What Is Hidradenitis Suppurativa?

Hidradenitis suppurativa (HS), also called acne inversa, is a chronic, recurrent, painful inflammatory disease of the hair follicle that affects skin rich in apocrine glands – the armpits (axilla), groin, under the breasts (inframammary), perianal region, and buttocks. For decades it was misclassified as an infectious or hygiene-related condition, but the modern understanding is clear: HS is an autoinflammatory disease that begins in the hair follicle, not a skin infection you "caught" or caused by poor cleaning.

Epidemiologically, HS affects roughly 1-4% of the population, is about three times more common in women than men, and usually begins between ages 18 and 40. One of the most frustrating realities for patients is the diagnostic delay: it commonly takes 7 to 10 years from the first symptoms to an accurate diagnosis, during which lesions are often mistaken for boils, ingrown hairs, or recurrent infections.

Hurley Staging

Clinicians grade HS severity using the Hurley staging system, which guides treatment intensity:

• Stage I: Isolated abscesses, single or multiple, with no sinus tracts (tunnels) and no scarring.
• Stage II: Recurrent abscesses with sinus tract formation and scarring, but lesions remain separated from one another.
• Stage III: Multiple interconnected sinus tracts and abscesses across an entire region, with diffuse involvement.

HS rarely travels alone. Common comorbidities include metabolic syndrome (obesity and type 2 diabetes), inflammatory bowel disease – especially Crohn's disease, polycystic ovary syndrome (PCOS), depression and anxiety, and acne conglobata. The quality-of-life impact is profound: the pain scores reported by HS patients on visual analog scales often exceed those reported in many cancer pain studies. This is not a cosmetic nuisance; it is a serious, life-altering inflammatory disease that deserves both medical management and supportive nutrition.

2. The Autoinflammatory Pathology of HS

Understanding why sea moss may help requires understanding what actually drives HS. The disease follows a follicular occlusion cascade – a chain reaction that begins in the hair follicle and ends in destructive tunneling:

1. Follicular hyperkeratosis. Keratinocytes plug the hair follicle, the follicle ruptures, and its contents – sebum, keratin, and bacteria – spill into the surrounding dermis, where they trigger the innate immune system.
2. NLRP3 inflammasome activation. Macrophages and keratinocytes assemble the NLRP3 inflammasome, which processes and releases interleukin-1 beta (IL-1beta), the central mediator of HS.
3. Cytokine cascade. IL-1beta drives a downstream storm of TNF-alpha, IL-6, IL-17, and IL-23, recruiting neutrophils, forming abscesses, and building the sinus tracts that define advanced disease.
4. Chronic inflammation and scarring. Sustained inflammation activates fibroblasts, producing the scar tissue and sinus tracts that make HS so difficult to reverse.

The critical distinction: HS is not fundamentally an infection. While secondary colonizers such as Staphylococcus aureus, anaerobes, and Cutibacterium are commonly cultured from lesions, they are passengers, not drivers. This is precisely why antibiotics, which address bacterial colonization, do not resolve the underlying autoinflammatory process for most patients. It is also why biologics that target IL-1 and TNF-alpha, such as secukinumab and adalimumab, have been transformative: they shut down the inflammatory engine itself rather than its bacterial bystanders.

3. Fucoidan and IL-1beta / NF-kB Modulation

This is where sea moss becomes mechanistically interesting. Fucoidan, the sulfated polysaccharide found in sea moss and other marine algae, directly engages the primary inflammatory machinery of HS through several research-supported pathways:

• NLRP3 inflammasome. Fucoidan has been shown to inhibit NLRP3 assembly and the maturation and cleavage of IL-1beta – the same broad mechanism targeted by anakinra, the IL-1 receptor antagonist used off-label in some HS cases.
• NF-kB. Fucoidan inhibits NF-kB nuclear translocation in keratinocytes and macrophages, reducing transcription of IL-1beta, TNF-alpha, and IL-6 at the source rather than mopping them up one by one.
• Selectin inhibition. Structurally similar to heparan sulfate, fucoidan inhibits P-selectin and L-selectin, reducing the neutrophil recruitment that builds HS abscesses.
• TLR4 modulation. Fucoidan modulates TLR4 signaling, the pathway through which macrophages become activated by the follicular rupture contents spilled into the dermis.

4. Zinc: The Most Evidence-Based Nutritional Supplement for HS

Sea moss provides roughly 1.95 mg of zinc per 100g. Among all nutritional interventions studied in HS, zinc has the strongest evidence base by a wide margin:

• Clinical evidence. Case series and small randomized trials of zinc gluconate at 90 mg per day showed significant HS improvement in two prospective studies, with remission rates in one comparison approaching those of tetracycline.
• Mechanism. Zinc inhibits 5-alpha-reductase (reducing the sebaceous activity relevant to follicular plugging), provides antimicrobial activity against Staph aureus and anaerobes in lesions, exerts anti-inflammatory effects by inhibiting NF-kB in keratinocytes, and supports wound healing through zinc-dependent metalloproteinases.
• Wound healing. Zinc carboxypeptidase and matrix metalloproteinase (MMP) activity are required for sinus tract remodeling both during and after surgical management of HS.

An honest caveat on dosing: sea moss provides dietary zinc that supports your baseline zinc status, but the therapeutic HS trials used zinc gluconate at 90 mg per day in split doses – a level of supplementation well beyond sea moss's dietary content. Sea moss lays a nutritional foundation; for the zinc dose studied in HS, dedicated zinc gluconate supplementation (with food, and with copper monitoring) is needed alongside it.

5. Prebiotic Fiber and the Gut-Skin Axis in HS

Sea moss provides 30-40g of fiber per 100g, mostly as soluble prebiotic polysaccharides – and the gut-skin axis is one of the most compelling reasons to consider it for HS:

• Gut dysbiosis in HS. Multiple studies confirm that HS patients carry a significantly altered gut microbiome: reduced Bacteroidetes, increased Firmicutes, and fewer butyrate-producing bacteria such as Faecalibacterium prausnitzii and Akkermansia muciniphila.
• Gut permeability. Dysbiosis degrades tight junction integrity, allowing lipopolysaccharide (LPS) to translocate into systemic circulation, where it activates TLR4 and NF-kB, amplifying systemic inflammation and exacerbating HS flares.
• The Crohn's overlap. Roughly 8-12% of HS patients also have Crohn's disease – both autoinflammatory, both involving the gut, both sharing the IL-1 and TNF-alpha pathway.
• How sea moss helps. Its prebiotic fiber selectively feeds Lactobacillus and Bifidobacterium, increasing butyrate production, which reduces gut permeability and lowers systemic LPS, in turn dialing down the NF-kB drive behind HS flares.

There is an elegant double action here: butyrate is also a direct NLRP3 inflammasome inhibitor. So prebiotic fiber that boosts butyrate hits HS pathology twice – once by repairing the leaky gut that fuels systemic inflammation, and again by directly suppressing the same inflammasome that releases IL-1beta in HS lesions.

6. Selenium and Oxidative Stress in HS Skin

Sea moss provides approximately 7.8 mcg of selenium per 100g. Oxidative stress is a core engine of tissue destruction in HS:

• HS lesions show markedly elevated reactive oxygen species (ROS) from activated neutrophils undergoing oxidative burst – the primary tissue-destructive mechanism inside abscesses.
• Serum antioxidant capacity is significantly reduced in HS patients compared with controls across multiple studies.
• Glutathione peroxidase (GPx), a selenium-dependent enzyme, is the primary scavenger of the hydrogen peroxide generated by neutrophil NADPH oxidase.
• Selenium deficiency impairs GPx activity, increasing oxidative tissue damage in HS lesions.
• Selenium also supports the thioredoxin system that regulates redox-sensitive NF-kB activation: thioredoxin-1 reduces oxidized IkB-alpha, helping keep NF-kB inhibited.
• In scar tissue, selenium-dependent antioxidants protect fibroblasts during wound healing, potentially limiting excessive scarring.

Sea moss is not a high-dose selenium supplement, but it contributes selenium within a whole-food mineral matrix that supports the body's antioxidant defenses against the oxidative load HS generates.

7. Omega-3 Fatty Acids and Prostaglandin Balance

Sea moss contains ALA, the plant-form omega-3 precursor. The eicosanoid biology of HS makes omega-3 status genuinely relevant:

• HS lesions contain elevated prostaglandin E2 (PGE2), a potent vasodilator and pain mediator generated by COX-2 from arachidonic acid (AA), an omega-6 fatty acid.
• Omega-3 fatty acids (EPA and DHA) compete with AA for the COX-2 enzyme, reducing PGE2 production.
• EPA and DHA generate specialized pro-resolving mediators (SPMs) – resolvins and protectins – that actively resolve neutrophilic inflammation, directly relevant to HS abscess resolution.
• A small pilot study found that omega-3 supplementation (3.3g EPA plus DHA) reduced HS flare frequency and severity.
• HS patients often carry elevated omega-6 to omega-3 ratios.

The honest limitation: sea moss's ALA converts to EPA and DHA at low efficiency in the human body. For meaningful omega-3 effects in HS, marine omega-3 supplementation alongside sea moss is the practical approach.

8. Magnesium and PCOS-HS Overlap

Sea moss provides roughly 120-144 mg of magnesium per 100g. The PCOS-HS connection is one of the most underappreciated links in the disease. PCOS affects 20-30% of female HS patients, and the two conditions share two key drivers: hyperandrogenism – elevated androgens that drive the follicular hyperkeratosis that initiates HS – and insulin resistance.

Magnesium intersects both:

• Insulin sensitizing. Magnesium improves insulin receptor kinase activity, addressing the insulin resistance component of HS. This matters because hyperinsulinemia drives IGF-1, which drives androgen production, which drives the follicular plugging at the root of HS.
• Androgen reduction. Magnesium supplementation has been shown to reduce testosterone and DHEAS in hyperandrogenic women in several studies.
• Flare timing. Many women experience premenstrual HS flares that track with estrogen and progesterone fluctuation; magnesium helps modulate these hormonal swings.

For male HS patients, magnesium also helps reduce androgen-driven sebaceous activity, making it broadly relevant across the HS population.

9. Dietary Triggers and Anti-HS Nutrition

Diet does not cause HS, but several dietary factors have solid evidence as flare triggers, and avoiding them is a low-risk part of management:

• Dairy. Cow's milk proteins, especially A1 casein, raise IGF-1, which drives androgen-mediated follicular plugging. Cohort data show that dairy reduction improves HS in a subset of patients.
• Brewer's yeast. Saccharomyces cerevisiae antibody positivity appears in both HS and Crohn's, and many HS patients report flares with beer and yeast-containing foods.
• High-glycemic foods. Elevated insulin raises IGF-1 and androgens; a low-glycemic diet is associated with improved HS.
• Smoking. Up to 70% of HS patients smoke, and nicotine promotes the keratinocyte plugging that starts HS.

Where does sea moss fit? It is anti-inflammatory, has a low glycemic index, delivers prebiotic fiber for microbiome support, and contains no dairy and no brewer's yeast. In other words, sea moss aligns cleanly with the anti-HS dietary pattern rather than working against it.

10. Comparison Table: HS Anti-Inflammatory Support

How sea moss compares with three other commonly discussed anti-inflammatory supports for HS:

Sea moss stands out for combining a plausible IL-1beta/NF-kB mechanism with genuine gut microbiome support and a trace-mineral nutritional base – making it a foundation that pairs well with targeted supplements like zinc rather than competing with them.

12. How to Use Sea Moss for HS Support

A practical, food-first approach centered on 2 tablespoons of sea moss gel daily (approximately 14-28g):

The HS Nutritional Stack

• Sea moss gel: 2 tbsp daily, morning with food for mineral absorption.
• Zinc gluconate: 90 mg/day with food (the HS-studied dose); monitor copper, and take separately, 2-3 hours away from calcium-rich foods.
• Omega-3 fish oil: roughly 3g EPA plus DHA daily.
• Vitamin D: frequently deficient in HS; test and repletes as advised.

Dietary and Lifestyle

• Trial eliminating or reducing dairy and high-GI foods, allowing 4-6 weeks each for a meaningful read.
• Keep a trigger journal tracking flares alongside diet, stress, menstrual cycle, and smoking to identify your individual triggers.

On topical use: some users apply sea moss gel directly to skin (anecdotal only). Carrageenan's anti-inflammatory and film-forming properties are the rationale, but there are no clinical trials for topical use in HS, and open or draining lesions should be managed under dermatologist guidance. Set realistic expectations on timing: plan for 3-6 months of consistent use to assess the gut-skin axis benefit, since microbiome and inflammatory shifts are gradual.